1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    






















































































































    Hyperglycemia and the Fate of Apparent Diffusion Coefficient–Defined Ischemic Penumbra | American Journal of Neuroradiology  
    


















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      
Open Access

  
      
Hyperglycemia and the Fate of Apparent Diffusion Coefficient–Defined Ischemic Penumbra
  
    	
C. Rosso, Y. Attal, S. Deltour, N. Hevia-Montiel, S. Lehéricy, S. Crozier, D. Dormont, S. Baillet and Y. Samson

  
    	
American Journal of Neuroradiology May 2011,  32 (5) 852-856; DOI: https://doi.org/10.3174/ajnr.A2407 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Bruno  A, 
    2. Levine  SR, 
    3. Frankel  MR, 
    4. et al
    .
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59: 669–74

    Abstract/FREE Full Text
    

  2. 2.↵


    1. Capes  SE, 
    2. Hunt  D, 
    3. Malmberg  K, 
    4. et al
    .
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426–32

    Abstract/FREE Full Text
    

  3. 3.↵


    1. Leigh  R, 
    2. Zaidat  OO, 
    3. Suri  MF, 
    4. et al
    .
Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004; 35: 1903–07

    Abstract/FREE Full Text
    

  4. 4.↵


    1. Fuentes  B, 
    2. Castillo  J, 
    3. San José  B, 
    4. et al
    .
The prognostic value of capillary glucose levels in acute stroke. The GLycemia in Acute Stroke (GLIAS) study. Stroke 2009; 40: 562–68

    Abstract/FREE Full Text
    

  5. 5.↵


    1. Hamilton  MG, 
    2. Tranmer  BI, 
    3. Auer  RN
    .
Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995; 82: 262–68

    CrossRefPubMedWeb of Science
    

  6. 6.↵


    1. Pulsinelli  WA, 
    2. Waldman  S, 
    3. Rawlinson  D, 
    4. et al
    .
Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982; 32: 1239–46

    Abstract/FREE Full Text
    

  7. 7.↵


    1. Rehncrona  S, 
    2. Rosén  I, 
    3. Siesjö  BK
    .
Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. J Cereb Blood Flow Metab 1981; 1: 297–311

    PubMedWeb of Science
    

  8. 8.↵


    1. Alvarez-Sabín  J, 
    2. Molina  CA, 
    3. Ribó  M, 
    4. et al
    .
Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004; 35: 2493–98

    Abstract/FREE Full Text
    

  9. 9.↵


    1. Baird  TA, 
    2. Parsons  MW, 
    3. Phanh  T, 
    4. et al
    .
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208–14

    Abstract/FREE Full Text
    

  10. 10.↵


    1. Parsons  MW, 
    2. Barber  PA, 
    3. Desmond  PM, 
    4. et al
    .
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52: 20–28

    CrossRefPubMedWeb of Science
    

  11. 11.↵


    1. Ribo  M, 
    2. Molina  CA, 
    3. Delgado  P, 
    4. et al
    .
Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with rtPa. J Cereb Blood Flow Metab 2007; 27: 1616–22

    CrossRefPubMedWeb of Science
    

  12. 12.↵


    1. Neumann-Haefelin  T, 
    2. Wittsack  HJ, 
    3. Wenserski  F, 
    4. et al
    .
Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999; 30: 1591–97

    Abstract/FREE Full Text
    

  13. 13.↵


    1. Grandin  CB, 
    2. Duprez  TP, 
    3. Smith  AM, 
    4. et al
    .
Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002; 223: 361–70

    CrossRefPubMed
    

  14. 14.↵


    1. Parsons  MW, 
    2. Yang  Q, 
    3. Barber  PA, 
    4. et al
    .
Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001; 32: 1581–87

    Abstract/FREE Full Text
    

  15. 15.↵


    1. Albers  GW, 
    2. Thijs  VN, 
    3. Wechsler  L, 
    4. et al
    .
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508–17

    CrossRefPubMedWeb of Science
    

  16. 16.↵


    1. Montiel  NH, 
    2. Rosso  C, 
    3. Chupin  N, 
    4. et al
    .
Automatic prediction of infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps. Acad Radiol 2008; 15: 77–83

    CrossRefPubMed
    

  17. 17.↵


    1. Hevia-Montiel  N, 
    2. Rosso  C, 
    3. Chupin  M, 
    4. et al
    .
Automatic prediction of final infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps. Int J Comp Assist Radiol Surg 2006; 1: 115–17

    

  18. 18.↵


    1. Rosso  C, 
    2. Hevia-Montiel  N, 
    3. Deltour  S, 
    4. et al
    .
Prediction of infarct growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast material. Radiology 2009; 250: 184–92

    CrossRefPubMed
    

  19. 19.↵


    1. Detre  JA, 
    2. Zager  EL, 
    3. Alsop  DC, 
    4. et al
    .
Correlation of diffusion MRI and heat shock protein in a rat embolic stroke model. J Neurol Sci 1997; 148: 163–69

    CrossRefPubMedWeb of Science
    

  20. 20.↵


    1. Na  DG, 
    2. Thijs  VN, 
    3. Albers  GW, 
    4. et al
    .
Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. AJNR Am J Neuroradiol 2004; 25: 1331–36

    Abstract/FREE Full Text
    

  21. 21.↵


    1. Oppenheim  C, 
    2. Grandin  C, 
    3. Samson  Y, 
    4. et al
    .
Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke?
Stroke 2001; 32: 2486–91

    Abstract/FREE Full Text
    

  22. 22.↵


    1. Sakoh  M, 
    2. Ostergaard  L, 
    3. Gjedde  A, 
    4. et al
    .
Prediction of tissue survival after middle cerebral artery occlusion based on changes in the apparent diffusion of water. J Neurosurg 2001; 95: 450–58

    PubMed
    

  23. 23.↵


    1. Schaefer  PW, 
    2. Ozsunar  Y, 
    3. He  J, 
    4. et al
    .
Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol 2003; 24: 436–43

    Abstract/FREE Full Text
    

  24. 24.↵


    1. Neumann-Haefelin  T, 
    2. du Mesnil de Rochemont  R, 
    3. Fiebach  JB, 
    4. et al
    .
Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004; 35: 109–14

    Abstract/FREE Full Text
    

  25. 25.↵


    1. Luby  M, 
    2. Bykowski  JL, 
    3. Schellinger  PD, 
    4. et al
    .
Intra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI. Stroke 2006; 37: 2951–56

    Abstract/FREE Full Text
    

  26. 26.↵


    1. Stead  LG, 
    2. Gilmore  RM, 
    3. Arnand  N, 
    4. et al.
    
Interventions for controlling hyperglycaemia in acute ischemic stroke. (Protocol)
Cochrane Database of Systematic Reviews 2005; Issue 3. Art. No.: CD005346. DOI:10.1002/14651858. CD005346
  27. 27.↵


    1. McCormick  MT, 
    2. Muir  KW, 
    3. Gray  CS, 
    4. et al
    .
Management of hyperglycemia in acute stroke: how, when, and for whom?
Stroke 2008; 39: 2177–85

    FREE Full Text
    

  28. 28.↵


    1. Samson  Y, 
    2. Bruandet  M, 
    3. Lejeune  M, 
    4. et al
    .
Insulin in the treatment of ischemic stroke. Presse Med 2006; 35: 696–98

    CrossRefPubMed
    

  29. 29.↵


    1. Gray  CS, 
    2. Hildreth  AJ, 
    3. Sandercock  PA, 
    4. et al
    .
Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).
Lancet Neurol 2007; 6: 397–406

    CrossRefPubMedWeb of Science
    

  30. 30.↵


    1. Kent  TA, 
    2. Soukup  VM, 
    3. Fabian  RH
    .
Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke 2001; 32: 2318–27

    Abstract/FREE Full Text
    

  31. 31.↵


    1. Bruno  A, 
    2. Saha  C, 
    3. Williams  LS, 
    4. et al
    .
IV insulin during acute cerebral infarction in diabetic patients. Neurology 2004; 62: 1441–42

    FREE Full Text
    

  32. 32.↵


    1. Klijn  CJ, 
    2. Hankey  GJ
    .
American Stroke Association and European Stroke Initiative.
Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2003; 2: 698–701

    CrossRefPubMedWeb of Science
    

  33. 33.↵


    1. Kreisel  SH, 
    2. Berschin  UM, 
    3. Hammes  HP, 
    4. et al
    .
Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2008; 27: 167–75

    PubMed
    

  34. 34.↵


    1. Scott  JF, 
    2. Robinson  GM, 
    3. French  JM, 
    4. et al
    .
Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycaemia. J Neurol Neurosurg Psychiatry 2001; 70: 401–04

    Abstract/FREE Full Text
    

  35. 35.↵


    1. MR Stroke Collaborative Group, 
    2. Phan  TG, 
    3. Donnan  GA, 
    4. et al
    .
Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data. Stroke 2006; 37: 2521–25

    Abstract/FREE Full Text
    

  36. 36.↵


    1. Warach  S
    .
Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med 2001; 2: 38–44

    CrossRefPubMed
    

  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Hyperglycemia and the Fate of Apparent Diffusion Coefficient–Defined Ischemic Penumbra
  
    	
C. Rosso, Y. Attal, S. Deltour, N. Hevia-Montiel, S. Lehéricy, S. Crozier, D. Dormont, S. Baillet, Y. Samson

  
    	
 American Journal of Neuroradiology May 2011, 32 (5) 852-856; DOI: 10.3174/ajnr.A2407 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement